I think that is going to be a really hard thing for us to be able to p — Marion Pepper

"Were learning so much about this virus and the immune response to it in a way that weve never done previously."

"It is early days, and we have a lot of work left to do in this area. I think for us, really looking at the cells that can respond to the infection has given us a unique insight into even long-term COVID-19."

"There is a considerable amount of bias in peer review, and we need to come up with systems to extract that bias so that articles can be reviewed fairly."

"The one thing that matters is where we are in this whole pandemic. I would be watching what the variants are doing."

"The take-home is, so far, so good, but time will tell."

"We also need to strive to do more rigorous studies of human immune responses."